Aligos Therapeutics ALGS Balance Sheet (2019-2026)

NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Aligos Therapeutics Quarterly Balance Sheet

Periods 29 quarters
Latest Sep 2026

Aligos Therapeutics reported total assets of $0.05B and total liabilities of $0.04B for the quarter ended Sep 2026, down 57.0% year over year. This balance sheet covers 29 quarters of results from Sep 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
186.82M104.56M71.17M86.44M81.35M78.67M90.83M70.43M135.70M24.15M45.08M35.33M37.00M73.76M18.66M41.95M18.30M29.98M30.40M31.10M
Short-term InvestmentsInvestments (Current)
3.92M78.66M88.17M55.86M44.48M24.85M0.01M-0.03M0.00M88.59M49.46M39.59M19.94M64.10M104.28M57.15M59.54M24.93M
Cash & Current Investments
205.80M183.20M159.30M142.30M125.80M103.50M90.80M70.40M135.70M112.70M94.50M74.90M56.90M137.90M122.90M99.10M77.80M54.90M30.40M31.10M
Receivables - NetNet Receivables
27.78M
Receivables
27.78M
Work In Process
0.02M0.02M0.02M0.02M0.02M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Current Deferred Tax AssetsCurrent Deferred Tax
-109,560.00M-34,235.00M-56.52M
Prepaid Assets
13.53M10.30M8.32M7.71M7.60M5.52M3.36M4.14M5.31M5.11M4.96M4.79M5.09M5.23M4.89M4.23M4.91M4.55M3.93M2.94M
Current Assets
204.42M195.08M167.69M150.09M133.55M109.43M94.24M74.64M141.08M118.06M99.57M79.82M62.14M143.21M127.94M103.44M82.86M59.63M62.13M34.68M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
6.18M6.02M5.78M5.25M4.82M4.37M3.95M3.65M3.26M3.05M2.80M2.58M2.36M2.21M2.06M2.04M1.87M1.59M1.33M1.21M
Long-Term Investments
15.11M
Long-Term Deferred Tax
3,168.00M2,376.00M1.76M
Other Non-Current Assets
1.03M1.56M0.02M0.08M0.75M0.40M0.04M0.70M0.70M0.84M0.70M0.64M0.63M0.63M0.64M0.71M0.72M0.76M0.76M0.27M
Non-Current Assets
30.95M15.39M14.84M13.98M13.15M12.31M11.89M11.21M10.44M9.84M9.24M8.60M7.95M7.49M6.76M6.33M5.67M4.93M4.20M12.51M
Assets
235.37M210.47M182.52M164.07M146.69M121.74M106.13M85.85M151.53M127.90M108.81M88.43M70.09M150.70M134.71M109.76M88.53M64.56M66.33M47.19M
Liabilities
Current Liabilities
Accounts Payables
3.02M3.76M2.76M2.93M4.74M2.82M3.24M2.94M2.52M2.84M6.82M2.74M2.57M4.46M3.94M4.65M3.98M7.64M6.43M3.21M
Payables
3.02M3.76M2.76M2.93M4.74M2.82M3.24M2.94M2.52M2.84M6.82M2.74M2.57M4.46M3.94M4.65M3.98M7.64M6.43M3.21M
Accumulated Expenses
25.39M19.24M12.82M13.68M16.04M15.08M13.80M12.32M16.84M12.04M12.06M14.16M15.56M11.00M12.21M13.61M13.53M11.99M18.70M15.15M
Other Accumulated Expenses
1.24M1.14M0.86M0.91M1.47M2.27M1.44M1.26M6.63M2.84M2.71M2.75M5.38M3.85M3.82M4.83M3.25M4.26M7.03M4.13M
Current Leases
0.14M0.14M0.14M0.14M0.11M0.11M0.06M0.06M0.01M0.01M0.00M0.01M0.04M0.04M0.04M0.02M0.15M0.08M0.06M0.06M
Current Taxes
106.00M795.00M331.00M
Current Deferred Revenue
7.64M15.07M13.13M10.73M8.74M6.56M4.10M2.09M1.31M0.72M1.33M0.66M0.15M0.58M0.17M
Total Current Liabilities
38.96M41.36M31.65M30.54M33.13M28.08M27.23M22.47M23.91M18.88M23.56M20.96M21.74M18.95M20.27M21.99M21.23M23.32M28.34M19.60M
Non-Current Liabilities
Capital Leases
0.26M0.23M0.20M0.17M0.23M0.21M0.20M0.19M0.23M0.22M0.20M0.19M0.12M0.12M0.12M0.12M
Non-Current Deferred Revenue
5.01M3.25M1.56M
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
-3,168.00M-2,376.00M-1.76M
Operating Leases
11.29M10.85M10.30M9.65M9.20M8.61M8.97M8.33M7.67M6.99M6.28M5.55M4.80M4.27M3.22M2.38M1.53M0.66M0.29M10.66M
Other Non-Current Liabilities
0.13M0.13M0.13M0.13M2,055.00M27.60M41.97M11.49M11.60M72.37M
Total Non-Current Liabilities
0.13M57.45M45.41M41.92M-2,012.21M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M
Total Liabilities
50.64M57.58M45.54M42.06M42.79M36.99M36.50M31.03M59.45M68.11M41.58M38.33M99.07M34.25M32.84M37.93M34.99M32.77M34.44M35.88M
Shareholder's Equity
Common Equity
184.73M152.89M136.98M122.01M103.90M84.75M69.64M54.82M92.08M59.80M67.23M50.10M-28.97M116.45M101.87M71.83M53.55M31.79M31.88M11.31M
Liabilities and Shareholders Equity
235.37M210.47M182.52M164.07M146.69M121.74M106.13M85.85M151.53M127.90M108.81M88.43M70.09M150.70M134.71M109.76M88.53M64.56M66.33M47.19M
Retained Earnings
-303.10M-338.70M-358.61M-377.23M-399.12M-422.10M-440.90M-458.91M-486.80M-521.70M-516.60M-535.90M-618.01M-574.92M-590.80M-622.32M-642.20M-665.24M-666.75M-688.61M
Preferred Shares

Aligos Therapeutics Balance Sheet API

Pull Aligos Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ALGS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY